Table 2.
Baseline patient characteristics: dichotomous variables.
| Characteristics | CAUa (N=71) | ICBTb + CAU (N=62) | Total group (N=133) | P valuec | |||||||
|
|
Yes | No | Missing | Yes | No | Missing | Yes | No | Missing |
|
|
| Medical comorbidity | 36 | 32 | 3 | 30 | 30 | 2 | 66 | 62 | 5 | .74 | |
| Psychological comorbidity | 5 | 63 | 3 | 2 | 58 | 2 | 7 | 121 | 5 | .32 | |
| Employed | 28 | 40 | 3 | 28 | 33 | 1 | 56 | 73 | 4 | .59 | |
| Medication use | |||||||||||
|
|
Painkillers | 8 | 56 | 7 | 10 | 46 | 6 | 18 | 102 | 13 | .41 |
|
|
NSAIDSd | 29 | 35 | 7 | 23 | 33 | 6 | 52 | 68 | 13 | .64 |
|
|
DMARDSe | 52 | 12 | 7 | 46 | 10 | 6 | 98 | 22 | 13 | .90 |
|
|
Corticoids | 13 | 51 | 7 | 12 | 44 | 6 | 25 | 95 | 13 | .88 |
|
|
Biologicals | 21 | 43 | 7 | 24 | 32 | 6 | 45 | 75 | 13 | .26 |
|
|
Mental Health Medication | 6 | 58 | 7 | 4 | 52 | 6 | 10 | 110 | 13 | .66 |
aCAU: care as usual.
bICBT: internet-based cognitive behavioral therapy.
cOutcome analysis; group differences at baseline were analyzed using chi-square analysis or independent samples t tests as appropriate.
dNSAID: Nonsteroidal antiinflammatory drugs.
eDMARD: disease modifying antirheumatic drugs.